Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019

Euro Surveill. 2019 Sep;24(37):1900549. doi: 10.2807/1560-7917.ES.2019.24.37.1900549.

Abstract

We recently isolated Candida auris from a blood culture and cutaneous swabs of a patient in her mid-70s. Our routine phenotypic methods failed to identify the microorganism, but it was identified by molecular tests and MALDI-TOF MS analysis. Our report, the first from Italy, further underlines the geographically wide distribution of C. auris and the need to confirm species identification of any suspicious colony as soon as possible to stop its spread.

Keywords: Candida; MDR; antifungal resistance; epidemic clone; epidemiology; fungal infection.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida / genetics
  • Candida / isolation & purification*
  • Candidiasis / diagnosis*
  • Candidiasis / drug therapy
  • Caspofungin / pharmacology
  • Caspofungin / therapeutic use
  • Drug Resistance, Multiple, Fungal
  • Female
  • Fever / etiology*
  • Humans
  • Italy
  • Microbial Sensitivity Tests
  • Postoperative Complications / virology
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods*
  • Vascular Diseases / complications*
  • Vascular Diseases / surgery

Substances

  • Antifungal Agents
  • Caspofungin